Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00227695 · COMPLETED
Trial details
- NCT number
- NCT00227695
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-08
- Primary completion
- 2013-05-03
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.